FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and can be used in differential diagnostics of myopia and glaucoma associated with myopia. That is ensured by visually assessing changes in the peripapillary retina and vessels of Haller-Zinn arterial peripapillary circle. In the presence of the beta-zone, reduced density of choriocapillaries with exposure of large vessels of the arterial circle of Haller-Zinn and formation of non-perfusion zones in peripapillary atrophy, glaucoma is diagnosed on the myopic eye.
EFFECT: method provides detecting differential diagnostic criteria of myopia and glaucoma associated with myopia, high accuracy of diagnosing glaucoma accompanying a pathology.
1 cl, 7 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING INITIAL MANIFESTATIONS OF PRIMARY OPEN-ANGLE GLAUCOMA | 2022 |
|
RU2778966C1 |
| METHOD FOR EARLY DIAGNOSIS OF PRIMARY OPEN-ANGLE GLAUCOMA | 2019 |
|
RU2698931C1 |
| METHOD OF TREATING ISCHEMIC TYPE OF PRIMARY OPEN-ANGLE GLAUCOMA IN INDIVIDUALS WITH NEAT SIGHT | 2010 |
|
RU2438670C1 |
| METHOD OF PREVENTION OF THE PROGRESSION OF PRIMARY OPEN-ANGLE GLAUCOMA | 2023 |
|
RU2799582C1 |
| METHOD OF TWO-STAGE SURGICAL TREATMENT OF CATARACT IN COMBINATION WITH PRIMARY OPEN-ANGLE GLAUCOMA | 2022 |
|
RU2796869C1 |
| METHOD FOR REPEAT MICROPULSE TRANSSCLERAL CYCLOPHOTOCOAGULATION IN VARIOUS STAGES OF REFRACTORY GLAUCOMA | 2021 |
|
RU2779993C1 |
| METHOD OF PREDICTING RISK OF DEVELOPING OPTIC NEUROPATHY WITH NORMOTENSIVE GLAUCOMA | 2015 |
|
RU2593891C1 |
| METHOD FOR PREDICTING THE RISK OF PRIMARY OPEN-ANGLE GLAUCOMA | 2020 |
|
RU2752031C1 |
| METHOD FOR PREDICTING CLINICAL VARIANTS OF GLAUCOMA IN PATIENTS WITH MYOPIC REFRACTION | 2003 |
|
RU2242914C1 |
| METHOD OF TREATING DISCIRCULATORY VERSION OF PRIMARY OPEN-ANGLE GLAUCOMA IN PEOPLE WITH MYOPIC REFRACTION | 2010 |
|
RU2449764C1 |
